Activation of p53-dependent/-independent pathways of apoptotic cell death by chelerythrine in a murine T cell lymphoma

References

• Promerantz JH, Blau HM. Tumor suppressor: enhancers or suppressor of regeneration? Development 2013;140:2502–2512.
   PubMed Web of Science ®Google Scholar
• Hussain SP, Harris CC. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998;58:4023–4037.
   PubMed Web of Science ®Google Scholar
• Dean JL, Knudsen KE. The role of tumor suppressor dysregulation in prostate cancer progression. Curr Drug Targets 2013;14:460–471.
   PubMed Web of Science ®Google Scholar
• Chang F, Syrjanen S, Kurvinen K, et al. The tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 1993;88:174–186.
   PubMed Web of Science ®Google Scholar
• Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann NY Acad Sci 2000;910:121–137.
   PubMed Web of Science ®Google Scholar
• Corrada E, Mennuni MG, Grieco N, et al. Neurological recovery after out-of-hospital cardiac arrest: hospital admission predictors and one-year survival in an urban cardiac network experience. Minerva Cardioangiol 2013;61:451–460.
   PubMedGoogle Scholar
• Botchkarev VA, Komarova EA, Siebenhaar F, et al. p53 involvement in the control of murine hair follicle regression. Am J Pathol 2001;158:1913–1919.
   PubMed Web of Science ®Google Scholar
• Gudkov AV, Komarova EA. Pathogenesis associated with the p53 response. Cold Spring Harb Perspect Biol 2010;2:a001180.
   Google Scholar
• Gudkov AV, Komarova EA. Prospective therapeutic applications of p53 inhibitors. Biochem Biophys Res Commun 2005;331:726–736.
   Google Scholar
• Komarova EA, Antoch MP, Novototskaya LR, et al. Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice. Aging (Albany NY) 2012;4:709–714.
   PubMedGoogle Scholar
• Komarova EA, Christov K, Faerman AI, et al. Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene 2000;19:3791–3798.
   PubMed Web of Science ®Google Scholar
• Komarova EA, Gudkov AV. Suppression of p53: a new approach to overcome side effects of antitumor therapy. Biochemistry (Mosc) 2000;65:41–48.
   PubMed Web of Science ®Google Scholar
• Oren M. Regulation of the p53 tumor suppressor protein. J Biol Chem 1999;274:36031–36034.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E, Resnitzky D, Lotem J, et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991;352:345–347.
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E, Deguin V, Zaitchouk T, et al. Transcriptional activation plays a role in the induction of apoptosis by transiently tranfected wild type p53. Oncogene 1995;11:2197–2205.
   PubMed Web of Science ®Google Scholar
• Ventura A, Kirsch DG, McLaughlin ME, et al. Regulation of p53 function leads to tumor regression in vivo. Nature 2007;445: 661–665.
   PubMed Web of Science ®Google Scholar
• Lane DP, Cheok CF, Brown C, et al. Mdm2 and p53 are highly conserved from placozoans to man. Cell Cycle 2010;9:540–547.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80: 293–299.
   PubMed Web of Science ®Google Scholar
• Nakano K, Vousden KH. PUMA: a novel pro-apoptotic gene, is induced by p53. Mol Cell 2001;7:683–694.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhang L, Hwang PM, et al. PUMA: induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001;7:673–682.
   PubMed Web of Science ®Google Scholar
• Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000;288:1053–1058.
   PubMed Web of Science ®Google Scholar
• Lin Y, Ma W, Benchimol S. Pidd: a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet 2000;26:124–127.
   Google Scholar
• Johnson CL, Lu D, Huang J, et al. Regulation of p53 stabilization by DNA damage and protein kinase C. Mol Cancer Ther 2002;1:861–867.
   PubMed Web of Science ®Google Scholar
• Lowe SW, Schmitt EM, Smith SW, et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993;362:847–849.
   PubMed Web of Science ®Google Scholar
• Wallace-Brodeur RR, Lowe SW. Clinical implications of p53 mutations. Cell Mol Life Sci 1999;55:64–75.
   PubMed Web of Science ®Google Scholar
• Gohel A, McCarthy MB, Gronowicz G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 1999;140:5339–5347.
   PubMed Web of Science ®Google Scholar
• George J, Singh M, Srivastava AK, et al. Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and P53. PLoS One 2011;6:e23395.
   PubMed Web of Science ®Google Scholar
• Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030–9040.
   PubMed Web of Science ®Google Scholar
• Clarke AR, Purdie CA, Harrison DJ, et al. Thymocytes apoptosis induced by p53 dependent and independent pathways. Nature 1993;362:849–852.
   PubMed Web of Science ®Google Scholar
• Kaminskyy VO, Lootsik MD, Stoika RS. Correlation of the cytotoxic activity of four different alkaloids, from Chelidonium majus (greater celandine), with their DNA intercalating properties and ability to induce breaks in the DNA of NK/Ly murine lymphoma cells. Central Eur J Biol 2006;1:2–15.
   Web of Science ®Google Scholar
• Siliciano JD, Canman CE, Taya Y, et al. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 1997;11: 3471–3481.
   PubMed Web of Science ®Google Scholar
• Cheronov MV, Stark GR. P53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate. Oncogene 1997;14:2503–2510.
   PubMed Web of Science ®Google Scholar
• Nanua S, Yoshimura FK. Different cell killing by lymphomagenic murine leukemia viruses occurs independent of p53 activation and mitochondriaal damage. J Virol 2004;78:5088–5096.
   PubMed Web of Science ®Google Scholar
• Kumar S, Acharya A. Chelerythrine induces reactive oxygen species-dependent mitochondrial apoptotic pathway in a murine T cell lymphoma. Tumor Biol 2014;35:129–140.
   PubMed Web of Science ®Google Scholar
• Jarvis WD, Turner AJ, Povirk LF, et al. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukaemia cells by pharmacological inhibitor of protein kinase C. Cancer Res 1994;54:1707–1714.
   PubMed Web of Science ®Google Scholar
• Oren M. Regulation of the p53 tumor suppressor protein. J Biol Chem 1999;274:36031–36034.
   PubMed Web of Science ®Google Scholar
• Kubbutat MHG, Vousden KH. Keeping an old friend under control: regulation of p53 stability. Mol Med Today 1998;4:250–256.
   PubMedGoogle Scholar
• Momand J, Wu H, Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene (Amst) 2000;242:15–29.
   PubMed Web of Science ®Google Scholar
• Siliciano JD, Canman CE, Taya Y, et al. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 1997;11: 3471–3481.
   PubMed Web of Science ®Google Scholar
• Meek DW. Multisite phosphorylation and the integration of stress signals at p53. Cell Signal 1998;10:159–166.
   PubMed Web of Science ®Google Scholar
• Chernov MV, Bean LJH, Lerner N, et al. Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation. J Biol Chem 2001;276:31819–31824.
   PubMed Web of Science ®Google Scholar
• Hengstermann A, Linares LK, Ciechanover A, et al. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc Natl Acad Sci USA 2001;98: 1218–1223.
   PubMedGoogle Scholar
• Chernov MV, Ramana CV, Adler VV, et al. Stabilization and activation of p53 are regulated independently by different phosphorylation events. Proc Natl Acad Sci USA 1998;95:2284–2289.
   PubMed Web of Science ®Google Scholar
• Walterova D, Ulrichova J, Valka I, et al. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta Univ Palacki Olomuc Fac Med 1995;139:7–16.
   PubMedGoogle Scholar
• Basu A, Haldar S. The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 1998;4:1099–1109.
   PubMed Web of Science ®Google Scholar
• Raisova M, Hossini AM, Eberle J, et al. The Bax/Bcl2 ratio determines the susceptibility of human melanoma cells to to CD95/Fas-mediated apoptosis. J Invest Dermatol 2001;117:333–340.
   PubMed Web of Science ®Google Scholar
• Bailey SG, Sanchez-Elsner T, Stephanou A, et al. Regulating genome surveillance system: miRNA and the p53 super family. Apoptosis 2010;15:541–552.
   PubMed Web of Science ®Google Scholar
• Hammerova J, Uldrijan S, Taborska E, et al. Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. J Dermatol Sci 2011;62:22–35.
   PubMed Web of Science ®Google Scholar